Thermo Fisher Scientific Q3 FY25: where the revenue came from and where it went
The whole income statement of Thermo Fisher Scientific for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jun 29 – Sep 27, 2025
- Reported
- Oct 31, 2025
Revenue$11.12B
+5% year over year
Gross profit$4.45B
40% margin
Operating profit$1.94B
17% margin
Net profit$1.62B
15% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 11.12 | 100% | +5% |
| Consumables | 4.68 | 42% | +7% |
| Services | 4.63 | 42% | +4% |
| Instruments | 1.81 | 16% | +2% |
| Cost of revenue | −6.67 | 60% | |
| Gross profit | 4.45 | 40% margin | +0pp |
| R&D | −0.35 | 3% | +0pp |
| SG&A | −2.16 | 20% | +0pp |
| Operating profit | 1.94 | 17% margin | +0pp |
| Interest & other costs | −0.12 | ||
| Tax | −0.21 | ||
| Net profit | 1.62 | 15% margin | −1pp |
214 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest